Are Biotage AB (publ) (STO:BIOT) Investors Paying Above The Intrinsic Value?
Jan 06
Swedish (OMX) Life Sciences Industry Analysis
UpdatedFeb 03, 2023
DataAggregated Company Financials
Companies13
- 7D10.0%
- 3M29.0%
- 1Y-31.9%
- YTD9.7%
AddLife is up 3.5%, leading the way for the Life Sciences industry, which has gained 3.3%. Meanwhile, Magle Chemoswed Holding actually underperformed within the industry, shrinking 6.7% in the last week. However, the industry is down 40% over the past year. Looking forward, earnings are forecast to decline by 36% per year.
Industry Valuation and Performance
Has the Swedish Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 03 Feb 2023 | kr43.6b | kr14.2b | kr943.9m | 39.3x | 46.1x | 3.1x |
| Sun, 01 Jan 2023 | kr39.8b | kr14.1b | kr944.3m | 41.4x | 42.2x | 2.8x |
| Tue, 29 Nov 2022 | kr37.4b | kr14.1b | kr944.3m | 41.4x | 39.6x | 2.6x |
| Thu, 27 Oct 2022 | kr37.8b | kr13.5b | kr750.9m | 55.1x | 50.3x | 2.8x |
| Sat, 24 Sep 2022 | kr33.2b | kr13.5b | kr750.9m | 48.4x | 44.2x | 2.5x |
| Mon, 22 Aug 2022 | kr41.5b | kr13.2b | kr658.2m | 43.7x | 63x | 3.1x |
| Wed, 20 Jul 2022 | kr40.7b | kr13.0b | kr650.4m | 41.3x | 62.6x | 3.1x |
| Fri, 17 Jun 2022 | kr44.1b | kr13.2b | kr753.4m | 40.4x | 58.5x | 3.3x |
| Sun, 15 May 2022 | kr51.4b | kr12.9b | kr749.4m | 45.9x | 68.6x | 4x |
| Tue, 12 Apr 2022 | kr66.1b | kr11.8b | kr732.3m | 55.2x | 90.3x | 5.6x |
| Thu, 10 Mar 2022 | kr55.7b | kr11.8b | kr745.4m | 46.6x | 74.8x | 4.7x |
| Sat, 05 Feb 2022 | kr53.9b | kr10.9b | kr788.9m | 46.8x | 68.4x | 4.9x |
| Mon, 03 Jan 2022 | kr89.1b | kr10.8b | kr786.3m | 61.3x | 113.3x | 8.2x |
| Wed, 01 Dec 2021 | kr86.5b | kr10.8b | kr787.8m | 55.8x | 109.8x | 8x |
| Fri, 29 Oct 2021 | kr96.2b | kr10.5b | kr864.6m | 56.9x | 111.3x | 9.2x |
| Sun, 26 Sep 2021 | kr95.1b | kr9.9b | kr853.6m | 53.2x | 111.4x | 9.6x |
| Tue, 24 Aug 2021 | kr94.5b | kr9.9b | kr853.6m | 54x | 110.8x | 9.6x |
| Wed, 30 Jun 2021 | kr76.7b | kr9.9b | kr853.6m | 49.2x | 89.8x | 7.8x |
| Sat, 03 Apr 2021 | kr55.1b | kr8.5b | kr852.0m | 41x | 64.6x | 6.5x |
| Tue, 05 Jan 2021 | kr43.5b | kr7.7b | kr693.0m | 48x | 62.8x | 5.7x |
| Fri, 09 Oct 2020 | kr43.8b | kr6.7b | kr455.0m | 54.6x | 96.2x | 6.5x |
| Thu, 02 Jul 2020 | kr29.9b | kr6.3b | kr401.6m | 47.6x | 74.5x | 4.8x |
| Sun, 05 Apr 2020 | kr21.7b | kr5.9b | kr347.9m | 50.5x | 62.4x | 3.7x |
Price to Earnings Ratio
70.7x
Current Industry PE
- Investors are pessimistic on the Swedish Life Sciences industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 42.5x which is lower than its 3-year average PE of 78.5x.
- The 3-year average PS ratio of 5.7x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
- The earnings for companies in the Life Sciences industry have grown 40% per year over the last three years.
- Revenues for these companies have grown 36% per year.
- This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.
Industry Trends
Which industries have driven the changes within the Swedish Healthcare industry?
| SE Market | 5.10% | |
| Healthcare | 3.74% | |
| Life Sciences | 10.00% | |
| Clinical Research and Equipment | 10.00% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| ALIF B AddLife | kr128.70 | 14.9% +kr2.0b | -50.9% | PE26.3x | |
| BICO BICO Group | kr116.10 | 9.9% +kr737.5m | -34.8% | PE200.8x | |
| BIOT Biotage | kr172.00 | 6.2% +kr666.4m | -8.5% | PE47.3x | |
| GENO Genovis AB (publ.) | kr62.50 | 8.3% +kr314.2m | 8.7% | PE100x | |
| MCAP MedCap | kr235.50 | 1.7% +kr59.2m | 50.6% | PE29.6x |
